Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects
Česká a slovenská farmacie · 20.03.2025 · 74 (1) · 8-13
DOI: 10.36290/csf.2025.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Česká a slovenská farmacie, erschienen am 20.03.2025. Verfasst von Jan Juřica und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Vomiting, Nausea, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Juřica, J., & Turjap, M. (2025). Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects. Česká a slovenská farmacie, 74(1), 8-13. https://doi.org/10.36290/csf.2025.003
Vancouver
Juřica J, Turjap M. Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects. Česká a slovenská farmacie. 2025;74(1):8-13. doi:10.36290/csf.2025.003
BibTeX
@article{Juica2025,
author = {Juřica, Jan and Turjap, Miroslav},
title = {Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects},
journal = {Česká a slovenská farmacie},
year = {2025},
volume = {74},
number = {1},
pages = {8--13},
doi = {10.36290/csf.2025.003}
}
EUVIMED